+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07340671

Safety and Effectiveness of the Cutera 1726 nm Laser System for Treating Facial Papules in Frontal Fibrosing Alopecia

Led by University of Miami · Updated on 2026-07-24

10

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating the safety and effectiveness of the Cutera 1726 nm laser system, also known as AviClear, for treating facial papules in people with frontal fibrosing alopecia FFA. This study focuses on measuring changes in the size and appearance of these papules to better understand this treatment approach. Participants will receive three laser treatments spaced about four weeks apart. After the treatment sessions, they will be followed for approximately 12 weeks. The study lasts about 30 weeks in total, during which participants will attend up to five visits to receive treatments and assessments. Throughout the study, researchers will measure changes in papule size using dermatoscopy and ultrasound, count lesions through physical exams, and assess lesion depth with optical coherence tomography or ultrasound. Standardized photographs and physician global assessments will also evaluate changes. A blinded dermatologist will review data after completion. Participants will be monitored closely during this period to evaluate treatment effects and safety.

CONDITIONS

Brief Title

Facial Papules in Frontal Fibrosing Alopecia (FFA)

Research Team

M

Maria V Muniz

L

Leigh Nattkemper, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here